» Articles » PMID: 27832779

MiR-199a-3p Inhibits Cell Proliferation and Induces Apoptosis by Targeting YAP1, Suppressing Jagged1-Notch Signaling in Human Hepatocellular Carcinoma

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2016 Nov 12
PMID 27832779
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: miR-199a-3p was significantly downregulated in the majority of human hepatocellular carcinoma (HCC) tissues and HCC cell lines. Yes associated protein 1 (YAP1) was overexpressed in human HCC, which promoted HCC development and progression by upregulating Jagged1 and activating the Notch pathway. We searched potential targets of miR-199a-3p with DIANA, TargetScan and PicTar tools, and found that YAP1 is one of the potential targets. Based on these findings, we speculated that miR-199a-3p might suppress HCC growth by targeting YAP1, downregulating Jagged1 and suppressing the Notch pathway.

Results: We determined the expression of miR-199a-3p and YAP1 by quantitative Real-Time PCR (qRT-PCR) and western blot assays, respectively, and found downregulation of miR-199a-3p and upregulation of YAP1 in HCC cell lines. Cell proliferation and apoptosis assays showed that miR-199a-3p suppresses HCC cell proliferation and promotes apoptosis, and knockdown of YAP1 has similar role. Furthermore, we verified that miR-199a-3p can directly target YAP1. We further investigated and confirmed that miR-199a-3p and YAP1 regulate HCC cell proliferation and apoptosis through Jagged1-Notch signaling.

Conclusion: miR-199a-3p targets YAP1, downregulates Jagged1 and suppresses the Notch signaling to inhibit HCC cell proliferation and promote apoptosis. These findings provide new insights into the mechanism by which miR-199a-3p suppresses HCC cell proliferation and induces apoptosis.

Citing Articles

Overview of hepatocarcinogenesis focusing on cellular origins of liver cancer stem cells: a narrative review.

Eun J J Yeungnam Med Sci. 2024; 42:3.

PMID: 39523770 PMC: 11812091. DOI: 10.12701/jyms.2024.01088.


Genetic Alchemy unveiled: MicroRNA-mediated gene therapy as the Artisan craft in the battlefront against hepatocellular carcinoma-a comprehensive chronicle of strategies and innovations.

Murshed A, Alnoud M, Ahmad S, Ullah Khan S, Alissa M, Alsuwat M Front Genet. 2024; 15:1356972.

PMID: 38915826 PMC: 11194743. DOI: 10.3389/fgene.2024.1356972.


Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.

Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S Signal Transduct Target Ther. 2024; 9(1):128.

PMID: 38797752 PMC: 11128457. DOI: 10.1038/s41392-024-01828-x.


Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.

Liang C, Long K, Zheng W, Zhong R, Li Z, Zhu S Medicine (Baltimore). 2024; 103(18):e38028.

PMID: 38701314 PMC: 11062718. DOI: 10.1097/MD.0000000000038028.


Circular RNA hsa_circ_0051246 acts as a microRNA-375 sponge to promote the progression of gastric cancer stem cells YAP1.

Deng M, Xu Y, Yao Y, Wang Y, Yan Q, Cheng M PeerJ. 2024; 11:e16523.

PMID: 38505381 PMC: 10950207. DOI: 10.7717/peerj.16523.


References
1.
Villanueva A, Alsinet C, Yanger K, Hoshida Y, Zong Y, Toffanin S . Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology. 2012; 143(6):1660-1669.e7. PMC: 3505826. DOI: 10.1053/j.gastro.2012.09.002. View

2.
Paul S, Shalimar , Sreenivas V, Gamanagatti S, Sharma H, Dhamija E . Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction. Aliment Pharmacol Ther. 2015; 41(10):961-71. DOI: 10.1111/apt.13173. View

3.
Farazi P, DePinho R . Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006; 6(9):674-87. DOI: 10.1038/nrc1934. View

4.
Duan Q, Wang X, Gong W, Ni L, Chen C, He X . ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One. 2012; 7(2):e31518. PMC: 3281082. DOI: 10.1371/journal.pone.0031518. View

5.
Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View